{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:00:49Z","timestamp":1788782449481,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s00415-022-11045-7","type":"journal-article","created":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T19:03:00Z","timestamp":1646161380000},"page":"4222-4228","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Three cases of Creutzfeldt\u2013Jakob disease presenting with a predominant dysexecutive syndrome"],"prefix":"10.1007","volume":"269","author":[{"given":"Nick","family":"Corriveau-Lecavalier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay K.","family":"Ramanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Drubach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory S.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4807-9833","authenticated-orcid":false,"given":"David T.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,1]]},"reference":[{"key":"11045_CR1","first-page":"155","volume-title":"Sporadic Creutzfeldt-Jakob disease. Handbook of clinical neurology","author":"I Zerr","year":"2018","unstructured":"Zerr I, Parchi P (2018) Sporadic Creutzfeldt-Jakob disease. Handbook of clinical neurology. Elsevier, New York, pp 155\u2013174"},{"issue":"4","key":"11045_CR2","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3233\/JAD-180123","volume":"64","author":"S Baiardi","year":"2018","unstructured":"Baiardi S, Capellari S, Stella AB, Parchi P (2018) Unusual clinical presentations challenging the early clinical diagnosis of Creutzfeldt-Jakob disease. J Alzheimer\u2019s Dis 64(4):1051\u20131065","journal-title":"J Alzheimer\u2019s Dis"},{"key":"11045_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaa068","author":"RA Townley","year":"2020","unstructured":"Townley RA, Graff-Radford J, Mantyh WG, Botha H, Polsinelli AJ, Przybelski SA et al (2020) Progressive dysexecutive syndrome due to Alzheimer\u2019s disease: a description of 55 cases and comparison to other phenotypes. Brain Commun. https:\/\/doi.org\/10.1093\/braincomms\/fcaa068","journal-title":"Brain Commun"},{"issue":"7","key":"11045_CR4","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1001\/archneur.1991.00530190071018","volume":"48","author":"E Kokmen","year":"1991","unstructured":"Kokmen E, Smith GE, Petersen RC, Tangalos E, Ivnik RC (1991) The short test of mental status: correlations with standardized psychometric testing. Arch Neurol 48(7):725\u2013728","journal-title":"Arch Neurol"},{"issue":"8","key":"11045_CR5","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/j.mayocp.2019.01.043","volume":"94","author":"RA Townley","year":"2019","unstructured":"Townley RA, Syrjanen JA, Botha H, Kremers WK, Aakre JA, Fields JA et al (2019) Comparison of the short test of mental status and the montreal cognitive assessment across the cognitive spectrum. Mayo Clin Proc 94(8):1516\u20131523","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"11045_CR6","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W","volume":"46","author":"P Parchi","year":"1999","unstructured":"Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O et al (1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46(2):224\u2013233","journal-title":"Ann Neurol"},{"key":"11045_CR7","unstructured":"Corriveau-Lecavalier N, Machulda MM, Botha H, Graff-Radford J, Knopman DS, Lower VJ, et al. Phenotypic subtypes of progressive dysexecutive syndrome due to Alzheimer\u2019s disease: a series of clinical cases. J Neurol. (accepted)."},{"issue":"2","key":"11045_CR8","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3233\/JAD-150668","volume":"50","author":"S Baiardi","year":"2016","unstructured":"Baiardi S, Capellari S, Ladogana A, Strumia S, Santangelo M, Pocchiari M et al (2016) Revisiting the Heidenhain variant of Creutzfeldt-Jakob disease: evidence for prion type variability influencing clinical course and laboratory findings. J Alzheimer\u2019s Dis 50(2):465\u2013476","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"9","key":"11045_CR9","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1007\/s00415-014-7410-z","volume":"261","author":"A Krasnianski","year":"2014","unstructured":"Krasnianski A, Kaune J, Jung K, Kretzschmar HA, Zerr I (2014) First symptom and initial diagnosis in sporadic CJD patients in Germany. J Neurol 261(9):1811\u20131817","journal-title":"J Neurol"},{"issue":"1","key":"11045_CR10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1080\/13554794.2018.1439067","volume":"24","author":"RA Townley","year":"2018","unstructured":"Townley RA, Dawson ET, Drubach DA (2018) Heterozygous genotype at codon 129 correlates with prolonged disease course in Heidenhain variant sporadic CJD: case report. Neurocase 24(1):54\u201358","journal-title":"Neurocase"},{"issue":"1","key":"11045_CR11","doi-asserted-by":"publisher","first-page":"e0190818","DOI":"10.1371\/journal.pone.0190818","volume":"13","author":"D Caine","year":"2018","unstructured":"Caine D, Nihat A, Crabb P, Rudge P, Cipolotti L, Collinge J et al (2018) The language disorder of prion disease is characteristic of a dynamic aphasia and is rarely an isolated clinical feature. PLoS ONE 13(1):e0190818","journal-title":"PLoS ONE"},{"issue":"3","key":"11045_CR12","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/ane.12600","volume":"135","author":"S El Tawil","year":"2017","unstructured":"El Tawil S, Chohan G, Mackenzie J, Rowe A, Weller B, Will RG et al (2017) Isolated language impairment as the primary presentation of sporadic Creutzfeldt Jakob disease. Acta Neurol Scand 135(3):316\u2013323","journal-title":"Acta Neurol Scand"},{"issue":"7","key":"11045_CR13","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1136\/jnnp.57.7.872","volume":"57","author":"E Tobias","year":"1994","unstructured":"Tobias E, Mann C, Bone I, De Silva R, Ironside J (1994) A case of Creutzfeldt-Jakob disease presenting with cortical deafness. J Neurol Neurosurg Psychiatry 57(7):872","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"11045_CR14","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1159\/000008250","volume":"44","author":"S Orimo","year":"2000","unstructured":"Orimo S, Ozawa E, Uematsu M, Yoshida E (2000) A case of Creutzfeldt-Jakob disease presenting with auditory agnosia as an initial manifestation. Eur Neurol 44(4):256","journal-title":"Eur Neurol"},{"issue":"6","key":"11045_CR15","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00415-002-0695-3","volume":"249","author":"K Henkel","year":"2002","unstructured":"Henkel K, Zerr I, Hertel A, Gratz K-F, Schr\u00f6ter A, Tschampa HJ et al (2002) Positron emission tomography with [18 F] FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD). J Neurol 249(6):699\u2013705","journal-title":"J Neurol"},{"issue":"3","key":"11045_CR16","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/j.1468-1331.2011.03570.x","volume":"19","author":"E Kim","year":"2012","unstructured":"Kim E, Cho S, Jeong B, Kim Y, Seo SW, Na DL et al (2012) Glucose metabolism in sporadic Creutzfeldt-Jakob disease: a statistical parametric mapping analysis of 18F-FDG PET. Eur J Neurol 19(3):488\u2013493","journal-title":"Eur J Neurol"},{"issue":"6","key":"11045_CR17","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1080\/19336896.2017.1387348","volume":"11","author":"D Renard","year":"2017","unstructured":"Renard D, Castelnovo G, Collombier L, Thouvenot E, Boudousq V (2017) FDG-PET in Creutzfeldt-Jakob disease: analysis of clinical-PET correlation. Prion 11(6):440\u2013453","journal-title":"Prion"},{"issue":"6","key":"11045_CR18","doi-asserted-by":"publisher","first-page":"e39731","DOI":"10.1371\/journal.pone.0039731","volume":"7","author":"DT Jones","year":"2012","unstructured":"Jones DT, Vemuri P, Murphy MC, Gunter JL, Senjem ML, Machulda MM et al (2012) Non-stationarity in the \u201cresting brain\u2019s\u201d modular architecture. PLoS ONE 7(6):e39731","journal-title":"PLoS ONE"},{"key":"11045_CR19","first-page":"fcaa068","volume":"2","author":"AD Jones","year":"2020","unstructured":"Jones AD, Lowe V, Botha H, Wiepert D, Murphy MC (2020) Patterns of neurodegeneration in dementia reflect a global functional state space. medRxiv 2:fcaa068","journal-title":"medRxiv"},{"issue":"9","key":"11045_CR20","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1046\/j.1460-9568.1999.00753.x","volume":"11","author":"F Binkofski","year":"1999","unstructured":"Binkofski F, Buccino G, Posse S, Seitz RJ, Rizzolatti G, Freund HJ (1999) A fronto-parietal circuit for object manipulation in man: evidence from an fMRI-study. Eur J Neurosci 11(9):3276\u20133286","journal-title":"Eur J Neurosci"},{"issue":"11","key":"11045_CR21","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.1523\/JNEUROSCI.08-11-04049.1988","volume":"8","author":"LD Selemon","year":"1988","unstructured":"Selemon LD, Goldman-Rakic PS (1988) Common cortical and subcortical targets of the dorsolateral prefrontal and posterior parietal cortices in the rhesus monkey: evidence for a distributed neural network subserving spatially guided behavior. J Neurosci 8(11):4049\u20134068","journal-title":"J Neurosci"},{"issue":"12","key":"11045_CR22","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1093\/brain\/awg279","volume":"126","author":"N Kapur","year":"2003","unstructured":"Kapur N, Abbott P, Lowman A, Will RG (2003) The neuropsychological profile associated with variant Creutzfeldt-Jakob disease. Brain 126(12):2693\u20132702","journal-title":"Brain"},{"issue":"5","key":"11045_CR23","doi-asserted-by":"publisher","first-page":"e247","DOI":"10.1097\/RLU.0000000000001602","volume":"42","author":"N Miyazawa","year":"2017","unstructured":"Miyazawa N (2017) Creutzfeldt-Jakob disease mimicking alzheimer disease and dementia with lewy bodies-findings of FDG PET with 3-dimensional stereotactic surface projection. Clin Nucl Med 42(5):e247\u2013e248","journal-title":"Clin Nucl Med"},{"issue":"9","key":"11045_CR24","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1016\/S1388-2457(03)00109-3","volume":"114","author":"DM Cambier","year":"2003","unstructured":"Cambier DM, Kantarci K, Worrell GA, Westmoreland BF, Aksamit AJ (2003) Lateralized and focal clinical, EEG, and FLAIR MRI abnormalities in Creutzfeldt-Jakob disease. Clin Neurophysiol 114(9):1724\u20131728","journal-title":"Clin Neurophysiol"},{"issue":"17","key":"11045_CR25","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1212\/WNL.0000000000002617","volume":"86","author":"AM Feyissa","year":"2016","unstructured":"Feyissa AM, Wirrell EC, Jones DT, Young NP, Britton JW (2016) Focal photoparoxysmal response in the Heidenhain variant of CJD: hidden from view! Neurology 86(17):1647\u20131648","journal-title":"Neurology"},{"issue":"5","key":"11045_CR26","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.clinph.2005.12.007","volume":"117","author":"HG Wieser","year":"2006","unstructured":"Wieser HG, Schindler K, Zumsteg D (2006) EEG in Creutzfeldt-Jakob disease. Clin Neurophysiol 117(5):935\u2013951","journal-title":"Clin Neurophysiol"},{"issue":"2","key":"11045_CR27","doi-asserted-by":"publisher","first-page":"fcaa127","DOI":"10.1093\/braincomms\/fcaa127","volume":"2","author":"DT Jones","year":"2020","unstructured":"Jones DT (2020) Multiple aetiologies of the progressive dysexecutive syndrome and the importance of biomarkers. Brain Commun 2(2):fcaa127","journal-title":"Brain Commun"},{"issue":"2","key":"11045_CR28","doi-asserted-by":"publisher","first-page":"fcaa126","DOI":"10.1093\/braincomms\/fcaa126","volume":"2","author":"M T\u00e1buas-Pereira","year":"2020","unstructured":"T\u00e1buas-Pereira M, Almeida MR, Duro D, Lima M, Dur\u00e3es J, Guerreiro R et al (2020) Patients with progranulin mutations overlap with the progressive dysexecutive syndrome: towards the definition of a frontoparietal dementia phenotype. Brain Comms 2(2):fcaa126","journal-title":"Brain Comms"},{"issue":"5","key":"11045_CR29","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1523\/JNEUROSCI.14-05-02775.1994","volume":"14","author":"HR Friedman","year":"1994","unstructured":"Friedman HR, Goldman-Rakic PS (1994) Coactivation of prefrontal cortex and inferior parietal cortex in working memory tasks revealed by 2DG functional mapping in the rhesus monkey. J Neurosci 14(5):2775\u20132788","journal-title":"J Neurosci"},{"issue":"1","key":"11045_CR30","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev.ne.11.030188.001033","volume":"11","author":"PS Goldman-Rakic","year":"1998","unstructured":"Goldman-Rakic PS (1998) Topography of cognition: parallel distributed networks in primate association cortex. Ann Rev Neurosci 11(1):137\u2013156","journal-title":"Ann Rev Neurosci"},{"issue":"3","key":"11045_CR31","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S1474-4422(20)30440-3","volume":"20","author":"J Graff-Radford","year":"2020","unstructured":"Graff-Radford J, Yong KX, Apostolova LG, Bouwman FH, Carrillo M, Dickerson BC et al (2020) New insights into atypical Alzheimer\u2019s disease in the era of biomarkers. The Lancet Neurol 20(3):222\u2013234","journal-title":"The Lancet Neurol"},{"issue":"6","key":"11045_CR32","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1212\/CON.0000000000001009","volume":"27","author":"DT Jones","year":"2021","unstructured":"Jones DT, Graff-Radford J (2021) Executive dysfunction and the prefrontal cortex. CONTINUUM Lifelong Learn Neurol 27(6):1586\u20131601","journal-title":"CONTINUUM Lifelong Learn Neurol"},{"issue":"5","key":"11045_CR33","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/ana.410280502","volume":"28","author":"MM Mesulam","year":"1990","unstructured":"Mesulam MM (1990) Large-scale neurocognitive networks and distributed processing for attention, language, and memory. Ann Neurol 28(5):597\u2013613","journal-title":"Ann Neurol"},{"issue":"3","key":"11045_CR34","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41583-021-00428-w","volume":"22","author":"LQ Uddin","year":"2021","unstructured":"Uddin LQ (2021) Cognitive and behavioural flexibility: neural mechanisms and clinical considerations. Nat Rev Neurosci 22(3):167\u2013179","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"11045_CR35","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1001\/archneur.63.6.876","volume":"63","author":"A Krasnianski","year":"2006","unstructured":"Krasnianski A, Meissner B, Schulz-Schaeffer W, Kallenberg K, Bartl M, Heinemann U et al (2006) Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt-Jakob disease. Arch Neurol 63(6):876\u2013880","journal-title":"Arch Neurol"},{"issue":"2","key":"11045_CR36","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1136\/practneurol-2016-001571","volume":"17","author":"S Mead","year":"2017","unstructured":"Mead S, Rudge P (2017) CJD mimics and chameleons. Pract Neurol 17(2):113\u2013121","journal-title":"Pract Neurol"},{"key":"11045_CR37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/00002093-199505000-00004","volume":"9","author":"K Herholz","year":"1995","unstructured":"Herholz K (1995) FDG PET and differential diagnosis of dementia. Alzheimer Dis Assoc Disord 9:6","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"11045_CR38","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1111\/imj.14890","volume":"51","author":"DP Nadebaum","year":"2020","unstructured":"Nadebaum DP, Krishnadas N, Poon AMT, Kalff V, Lichtenstein M, Villemagne VL et al (2020) A head-to-head comparison of cerebral blood flow SPECT and 18F-FDG PET in the diagnosis of Alzheimer\u2019s disease. Intern Med J 51:1243","journal-title":"Intern Med J"},{"issue":"10","key":"11045_CR39","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1093\/brain\/awp191","volume":"132","author":"I Zerr","year":"2009","unstructured":"Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U et al (2009) Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 132(10):2659\u20132668","journal-title":"Brain"},{"issue":"8","key":"11045_CR40","doi-asserted-by":"publisher","first-page":"e1017","DOI":"10.1212\/WNL.0000000000010086","volume":"95","author":"DD Rhoads","year":"2020","unstructured":"Rhoads DD, Wrona A, Foutz A, Blevins J, Glisic K, Person M et al (2020) Diagnosis of prion diseases by RT-QuIC results in improved surveillance. Neurology 95(8):e1017\u2013e1026","journal-title":"Neurology"},{"issue":"8","key":"11045_CR41","doi-asserted-by":"publisher","first-page":"e1017","DOI":"10.1212\/WNL.0000000000010086","volume":"95","author":"LB Schonberger","year":"2020","unstructured":"Schonberger LB, Tatsuoka C, Cohen ML (2020) Diagnosis of prion diseases by RT-QuIC results in improved surveillance. Neurology 95(8):e1017\u2013e1026","journal-title":"Neurology"},{"issue":"4","key":"11045_CR42","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00401-017-1683-0","volume":"133","author":"F Lattanzio","year":"2017","unstructured":"Lattanzio F, Abu-Rumeileh S, Franceschini A, Kai H, Amore G, Poggiolini I, Rossi M, Baiardi S, McGuire L, Ladogana A, Pocchiari M (2017) Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and A\u03b242 levels. Acta Neuropathol 133(4):559\u2013578","journal-title":"Acta Neuropathol"},{"issue":"3","key":"11045_CR43","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/sj.mp.4001220","volume":"8","author":"M Riemenschneider","year":"2003","unstructured":"Riemenschneider M, Wagenpfeil S, Vanderstichele H, Otto M, Wiltfang J, Kretzschmar H et al (2003) Phospho-tau\/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias. Mol Psychiatry 8(3):343\u2013347","journal-title":"Mol Psychiatry"},{"issue":"4","key":"11045_CR44","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1001\/jamaneurol.2013.6455","volume":"71","author":"T Skillb\u00e4ck","year":"2014","unstructured":"Skillb\u00e4ck T, Ros\u00e9n C, Asztely F, Mattsson N, Blennow K, Zetterberg H (2014) Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: results from the Swedish Mortality Registry. JAMA Neurol 71(4):476\u2013483","journal-title":"JAMA Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11045-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-022-11045-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11045-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T17:03:45Z","timestamp":1658163825000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-022-11045-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["11045"],"URL":"https:\/\/doi.org\/10.1007\/s00415-022-11045-7","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,1]]},"assertion":[{"value":"13 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"GS Day is supported by a career development grant from the NIH (K23AG064029). He owns stock (>\u2009$10,000) in ANI Pharmaceuticals (a generic pharmaceutical company). He serves as a topic editor for DynaMed (EBSCO), overseeing development of evidence-based educational content, and as the Clinical Director of the Anti-NMDA Receptor Encephalitis Foundation (Inc, Canada; uncompensated).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This retrospective study was approved by the Mayo Clinic Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All patients or their informant provided written consent for their clinical data to be used for research purposes.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}